Last checked at 19 May 2023 07:00
19th May 2023
VENTURE LIFE GROUP PLC
("Venture Life", "VLG" or the "Company")
Board change
Venture Life (AIM: VLG), a leader in developing, manufacturing and commercialising products for the self-care market, announces that Mrs Sharon Daly (nee Collins) will be leaving the Company on 3 August 2023 to pursue other opportunities and hence, will cease to be a director.
Sharon co-founded Venture Life in 2010 and since then, has made a significant contribution to the growth of the business. She has been pivotal in Venture Life's journey of growth over the years, and we would like to thank her for that.
Sharon leaves the business having played a significant role in taking Venture Life from a start up to the substantially bigger business that it is today, listed on AIM.
We would like to express our gratitude and thanks to Sharon for the hard work and support she has given to the business, and wish her the very best in her new endeavours.
Sharon will affect a smooth handover of her responsibilities before she finally leaves the business. At this point, Sharon's role of Chief Commercial Officer will not be replaced on the Board, but her role will be restructured across the existing team within the business, bolstered, if necessary, in due course, with any additional resource identified as needed.
For further information, please contact:
Venture Life Group PLC +44 (0) 1344 578004
Jerry Randall, Chief Executive Officer
Daniel Wells, Chief Financial Officer
Cenkos Securities plc (Nomad and Joint Broker) +44 (0) 20 7397 8900
Stephen Keys / Camilla Hume (Corporate Finance)
Russell Kerr / Michael Johnson (Sales)
Singer Capital Markets (Joint Broker)
Shaun Dobson / Alaina Wong (Corporate Finance) +44 (0) 20 74963000
Jonathan Dighe (Sales)
About Venture Life (www.venture-life.com)
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market. With operations in the UK, Italy, The Netherlands and Sweden, the Group's product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, the Balance Activ range in the area of women's intimate healthcare, the Lift and Glucogel product ranges for hypoglycaemia, Gelclair and Pomi-T for oncology support, products for fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing. Its products are sold in over 90 countries worldwide.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples. In the UK and The Netherlands these are supplied direct by the company to retailers, elsewhere they are supplied by the Group's international distribution partners.
Through its two Development & Manufacturing operations in Italy and Sweden, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.